Therefore, it is possible that transport of EAAT1-mediated L-Glu from the CSF and then GS-mediated conversion to L-glutamine play a role in preventing epileptic seizures, and this should be taken into consideration as therapeutic targets for the treatment of epilepsy. The gene discussed is GLUL; the disease is Seizure.